)
)
Philippe Sanseau
Senior Director,
GSK
Philippe Sanseau is a Senior Director at GlaxoSmithKline (GSK), with over 25 years of experience in computational biology. He has contributed to various projects in multiple therapeutic areas, participated in large collaborations, and is involved in multiple advisory boards.
He sits currently on the Open Targets Governance Board. Philippe has published over 50 peer-reviewed papers and holds a PhD from the University of Rennes.
Sessions
-
Revealing Biological Mechanisms Through Multi-Omics Analyses28-Jan-2026Multi-Omics Integration Stage